KLACID Side Effects

6916677-2 | Toxic Epidermal Necrolysis
on Aug 02, 2010 Male patient from SINGAPORE , 67 years of age, was diagnosed with myocardial ischaemia, hypertension, hyperlipidaemia and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Klacid dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TICLID (View Ticlid Review and Ticlid Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6909469-1 | Bronchopneumonia
Patient was taking Klacid (View Usage). Patient had the following side effects: bronchopneumonia on Jul 26, 2010 from CZECH REPUBLIC Additional patient health information: Male patient , 42 years of age, was diagnosed with bronchopneumonia, hypertension and. Klacid dosage: . During the same period patient was treated with EMZOK (View Emzok Review and Emzok Label ), TENAXUM (View Tenaxum Review and Tenaxum Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), NOLPAZA (View Nolpaza Review and Nolpaza Label ). Patient was hospitalized.

6888828-X | Aggression, Grand Mal Convulsion, Restlessness
Adverse event was reported on Jul 21, 2010 by a Male patient taking Klacid (View Usage) (Dosage: ) . Location: , 76 years of age, After Klacid was administered, patient had the following side effects: aggression, grand mal convulsion, restlessness. During the same period patient was treated with LEPONEX (View Leponex Review and Leponex Label ), DELIX (View Delix Review and Delix Label ), DELIX 2.5PLUS/ 5 PLUS (View Delix 2.5plus/-5 Plus Review and Delix 2.5plus/-5 Plus Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), LEVODOPA (View Levodopa Review and Levodopa Label ). Patient was hospitalized.

6870796-8 | Dehydration, Vertigo, Vomiting
on Jul 13, 2010 Female patient from CZECH REPUBLIC , weighting 160.9 lb, was diagnosed with bronchopneumonia, rheumatoid arthritis (What is rheumatoid arthritis?), body temperature increased, cough and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, vertigo, vomiting. Klacid dosage: . During the same period patient was treated with IBALGIN (View Ibalgin Review and Ibalgin Label ), PARALEN (Qid) (View Paralen Review and Paralen Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ). Patient was hospitalized.


6856729-9 | Chills, Clostridial Infection, Diarrhoea, Pyrexia
on Jul 09, 2010 Female patient from GERMANY , 71 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Klacid (View Usage). Patient had the following side effects: chills, clostridial infection, diarrhoea, pyrexia. Klacid dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), TAZOBAC (View Tazobac Review and Tazobac Label ). Patient was hospitalized.

6723254-5 | Mucosal Ulceration
Patient was taking Klacid (View Usage). After Klacid was administered, patient had the following side effects: mucosal ulceration on May 04, 2010 from SINGAPORE Additional patient health information: Female patient , 66 years of age, . Klacid dosage: .

6567100-1 | Lip Swelling, Paraesthesia Oral, Rash
Adverse event was reported on Jan 25, 2010 by a Female patient taking Klacid (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: AUSTRALIA , 45 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: lip swelling, paraesthesia oral, rash (What is rash?). During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), AVELOX (View Avelox Review and Avelox Label ), TAMIFLU (View Tamiflu Review and Tamiflu Label ).

6368386-9 | Asthenia, Gait Disturbance, Hearing Impaired, Sleep Disorder
on Sep 16, 2009 Male patient from IRELAND , 55 years of age, was diagnosed with mycoplasma infection and was treated with Klacid (View Usage). Patient had the following side effects: asthenia, gait disturbance, hearing impaired, sleep disorder (What is sleep disorder?). Klacid dosage: . During the same period patient was treated with ALUPENT (View Alupent Review and Alupent Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ).

6335792-8 | Bronchopneumonia, Condition Aggravated, Lung Abscess, Lung Neoplasm, Pneumonia Aspiration, Pyrexia, Respiratory Distress, Respiratory Failure
on Aug 21, 2009 Male patient from SWITZERLAND , 27 years of age, was diagnosed with bronchopneumonia and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: bronchopneumonia, condition aggravated, lung abscess, lung neoplasm, pneumonia aspiration, pyrexia, respiratory distress, respiratory failure. Klacid dosage: 500 Milligrams X 2. During the same period patient was treated with RISPERDAL (1 Milligrams X 2) (View Risperdal Review and Risperdal Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CEFEPIME (2 Grams X 2) (View Cefepime Review and Cefepime Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), KONAKION (View Konakion Review and Konakion Label ), CLEXANE (View Clexane Review and Clexane Label ), CETALLERG (View Cetallerg Review and Cetallerg Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6304572-1 | Aggression, Agitation, Aphthous Stomatitis, C-reactive Protein Increased, Disinhibition, Dry Mouth, Fatigue, Insomnia
Patient was taking Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, agitation, aphthous stomatitis, c-reactive protein increased, disinhibition, dry mouth, fatigue, insomnia on Aug 11, 2009 from SWITZERLAND Additional patient health information: Male patient , 38 years of age, weighting 169.8 lb, was diagnosed with pneumonia (What is pneumonia?), sarcoidosis and. Klacid dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), NSIADS (View Nsiads Review and Nsiads Label ), PREDNISOLONE (20mg + 10mg As Drops) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6301579-5 | Aggression, Agitation, Aphthous Stomatitis, C-reactive Protein Increased, Disinhibition, Dry Mouth, Fatigue, Insomnia
Adverse event was reported on Jul 29, 2009 by a Male patient taking Klacid (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), sarcoidosis and. Location: SWITZERLAND , 38 years of age, weighting 169.8 lb, Patient had the following side effects: aggression, agitation, aphthous stomatitis, c-reactive protein increased, disinhibition, dry mouth, fatigue, insomnia. During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), NSIADS (View Nsiads Review and Nsiads Label ), PREDNISOLONE (20mg + 10mg As Drops) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6296675-5 | Blood Prolactin Increased, Breast Discomfort, Breast Enlargement
on Jul 29, 2009 Female patient from GERMANY , 23 years of age, weighting 132.3 lb, was diagnosed with depression (What is depression?), helicobacter infection and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: blood prolactin increased, breast discomfort, breast enlargement. Klacid dosage: . During the same period patient was treated with PANTOZOL 40 MG (View Pantozol 40 Mg Review and Pantozol 40 Mg Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ATOSIL (View Atosil Review and Atosil Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), AGOMELATINE (VALDOXAN) (View Agomelatine (valdoxan) Review and Agomelatine (valdoxan) Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6293183-2 | Extrapyramidal Disorder, Muscle Rigidity, Parkinsonism
on Jul 23, 2009 Male patient from SWITZERLAND , 40 years of age, was diagnosed with gastritis, helicobacter infection, duodenitis, personality disorder (What is personality disorder?), brain injury and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, muscle rigidity, parkinsonism. Klacid dosage: . During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6288883-4 | Blood Prolactin Increased, Breast Discomfort, Breast Enlargement
Patient was taking Klacid (View Usage). Patient had the following side effects: blood prolactin increased, breast discomfort, breast enlargement on Jul 22, 2009 from GERMANY Additional patient health information: Female patient , 23 years of age, weighting 132.3 lb, was diagnosed with depression (What is depression?), helicobacter infection and. Klacid dosage: . During the same period patient was treated with PANTOZOL 40 MG (View Pantozol 40 Mg Review and Pantozol 40 Mg Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ATOSIL (View Atosil Review and Atosil Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), AGOMELATINE (VALDOXAN) (View Agomelatine (valdoxan) Review and Agomelatine (valdoxan) Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6286412-2 | Aggression, Agitation, Aphthous Stomatitis, Dry Mouth, Fatigue, Logorrhoea, Nervousness, Tension
Adverse event was reported on Jul 22, 2009 by a Male patient taking Klacid (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), sarcoidosis and. Location: SWITZERLAND , 38 years of age, weighting 169.8 lb, After Klacid was administered, patient had the following side effects: aggression, agitation, aphthous stomatitis, dry mouth, fatigue, logorrhoea, nervousness, tension. During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), NSIADS (View Nsiads Review and Nsiads Label ), PREDNISOLONE (20mg + 10mg As Drops) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6272785-3 | Arteriosclerosis, Arteriosclerosis Coronary Artery, Coronary Artery Disease, Electrocardiogram Qt Prolonged, Emphysema, Idiopathic Thrombocytopenic Purpura, Long Qt Syndrome, Myocardial Infarction, Pneumonia
on Jul 09, 2009 Male patient from GERMANY , 65 years of age, weighting 163.1 lb, was diagnosed with pyrexia and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, arteriosclerosis coronary artery, coronary artery disease (What is coronary artery disease?), electrocardiogram qt prolonged, emphysema, idiopathic thrombocytopenic purpura, long qt syndrome, myocardial infarction, pneumonia (What is pneumonia?). Klacid dosage: 250 Mg Once. During the same period patient was treated with AVELOX (400 Mg Od) (View Avelox Review and Avelox Label ), AMPICILLIN AND SULBACTAM (Unk.) (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ). Patient was hospitalized.

6271045-4 | Cardiac Failure, Dyspnoea, Ejection Fraction Abnormal, Empyema, Weight Increased
on Jul 03, 2009 Male patient from GERMANY , weighting 121.3 lb, was diagnosed with empyema and was treated with Klacid (View Usage). Patient had the following side effects: cardiac failure, dyspnoea, ejection fraction abnormal, empyema, weight increased. Klacid dosage: . Patient was hospitalized.

6267959-1 | Arteriosclerosis, Arteriosclerosis Coronary Artery, Coronary Artery Disease, Electrocardiogram Qt Prolonged, Emphysema, Idiopathic Thrombocytopenic Purpura, Long Qt Syndrome, Myocardial Infarction, Pneumonia
Patient was taking Klacid (View Usage). After Klacid was administered, patient had the following side effects: arteriosclerosis, arteriosclerosis coronary artery, coronary artery disease (What is coronary artery disease?), electrocardiogram qt prolonged, emphysema, idiopathic thrombocytopenic purpura, long qt syndrome, myocardial infarction, pneumonia (What is pneumonia?) on Jul 09, 2009 from GERMANY Additional patient health information: Male patient , 65 years of age, weighting 163.1 lb, was diagnosed with pyrexia and. Klacid dosage: 250 Mg Once. During the same period patient was treated with AVELOX (400 Mg Od) (View Avelox Review and Avelox Label ), AMPICILLIN AND SULBACTAM (Unk.) (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ). Patient was hospitalized.

6264743-X | Cardiac Failure, Dyspnoea, Ejection Fraction Abnormal, Empyema, Weight Increased
Adverse event was reported on Jul 01, 2009 by a Male patient taking Klacid (View Usage) (Dosage: ) was diagnosed with empyema and. Location: GERMANY , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, dyspnoea, ejection fraction abnormal, empyema, weight increased. Patient was hospitalized.

6261678-3 | Dysphagia, Oropharyngeal Blistering
on Jul 02, 2009 Female patient from DENMARK , 74 years of age, was diagnosed with diverticulitis and was treated with Klacid (View Usage). Patient had the following side effects: dysphagia, oropharyngeal blistering. Klacid dosage: .

6213020-1 | Renal Pain
on May 28, 2009 Female patient from AUSTRIA , 50 years of age, was diagnosed with helicobacter infection and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: renal pain. Klacid dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), PROTON PUMP INHIBITORS (View Proton Pump Inhibitors Review and Proton Pump Inhibitors Label ).

6196461-0 | Condition Aggravated, Haemodynamic Instability, Metabolic Acidosis, Respiratory Arrest, Respiratory Fatigue, Sepsis, Shock, Tachypnoea
Patient was taking Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, haemodynamic instability, metabolic acidosis, respiratory arrest, respiratory fatigue, sepsis (What is sepsis?), shock, tachypnoea on May 18, 2009 from SWITZERLAND Additional patient health information: Male patient , 65 years of age, was diagnosed with pyrexia, lung infection and. Klacid dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TIENAM (View Tienam Review and Tienam Label ), KONAKION (View Konakion Review and Konakion Label ), FOLVIT (View Folvit Review and Folvit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6187268-9 | Condition Aggravated, Haemodynamic Instability, Metabolic Acidosis, Respiratory Arrest, Respiratory Fatigue, Sepsis, Shock, Tachypnoea
Adverse event was reported on May 08, 2009 by a Male patient taking Klacid (View Usage) (Dosage: ) was diagnosed with pyrexia, lung infection and. Location: SWITZERLAND , 65 years of age, Patient had the following side effects: condition aggravated, haemodynamic instability, metabolic acidosis, respiratory arrest, respiratory fatigue, sepsis (What is sepsis?), shock, tachypnoea. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TIENAM (View Tienam Review and Tienam Label ), KONAKION (View Konakion Review and Konakion Label ), FOLVIT (View Folvit Review and Folvit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6180590-1 | Aplastic Anaemia
on Apr 27, 2009 Male patient from SPAIN , 72 years of age, was diagnosed with respiratory tract infection, chronic myeloid leukaemia and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: aplastic anaemia. Klacid dosage: Not Reported. During the same period patient was treated with PARACETAMOL (Not Reported) (View Paracetamol Review and Paracetamol Label ), AMOXICILLIN (Not Reported) (View Amoxicillin Review and Amoxicillin Label ), IBUPROFEN (Not Reported) (View Ibuprofen Review and Ibuprofen Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ). Patient was hospitalized.

6179368-4 | Condition Aggravated, Haemodynamic Instability, Metabolic Acidosis, Respiratory Arrest, Respiratory Fatigue, Sepsis, Shock, Tachypnoea
on Apr 30, 2009 Male patient from SWITZERLAND , 65 years of age, was diagnosed with pyrexia, lung infection and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, haemodynamic instability, metabolic acidosis, respiratory arrest, respiratory fatigue, sepsis (What is sepsis?), shock, tachypnoea. Klacid dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TIENAM (View Tienam Review and Tienam Label ), KONAKION (View Konakion Review and Konakion Label ), FOLVIT (View Folvit Review and Folvit Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6179345-3 | Aplastic Anaemia
Patient was taking Klacid (View Usage). Patient had the following side effects: aplastic anaemia on Apr 27, 2009 from SPAIN Additional patient health information: Male patient , 72 years of age, was diagnosed with respiratory tract infection, chronic myeloid leukaemia and. Klacid dosage: Not Reported. During the same period patient was treated with PARACETAMOL (Not Reported) (View Paracetamol Review and Paracetamol Label ), AMOXICILLIN (Not Reported) (View Amoxicillin Review and Amoxicillin Label ), IBUPROFEN (Not Reported) (View Ibuprofen Review and Ibuprofen Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ). Patient was hospitalized.

6165326-2 | Pseudomembranous Colitis, Septic Shock
Adverse event was reported on Apr 14, 2009 by a Female patient taking Klacid (View Usage) (Dosage: ) was diagnosed with bronchopneumonia, gastric ulcer and. Location: SWITZERLAND , 80 years of age, After Klacid was administered, patient had the following side effects: pseudomembranous colitis, septic shock. During the same period patient was treated with CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), CEFUROXIME AXETIL (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CALCIUM CARBONATE W/COLECALCIFEROL (View Calcium Carbonate W/colecalciferol Review and Calcium Carbonate W/colecalciferol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ). Patient was hospitalized.

6162160-4 | Toxic Epidermal Necrolysis
on Apr 14, 2009 Male patient from SINGAPORE , 67 years of age, was diagnosed with myocardial ischaemia, hypertension, hyperlipidaemia and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Klacid dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LOSEC (View Losec Review and Losec Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TICLID (View Ticlid Review and Ticlid Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6153447-X | Decreased Interest, Depersonalisation, Merycism, Suicidal Ideation
on Apr 09, 2009 Male patient from GERMANY , 52 years of age, was diagnosed with bronchitis bacterial and was treated with Klacid (View Usage). Patient had the following side effects: decreased interest, depersonalisation, merycism, suicidal ideation. Klacid dosage: .

6148732-1 | Toxic Epidermal Necrolysis
Patient was taking Klacid (View Usage). After Klacid was administered, patient had the following side effects: toxic epidermal necrolysis on Mar 31, 2009 from SINGAPORE Additional patient health information: Male patient , 67 years of age, was diagnosed with myocardial ischaemia, hypertension, hyperlipidaemia and. Klacid dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LOSEC (View Losec Review and Losec Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TICLID (View Ticlid Review and Ticlid Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6142943-7 | Toxic Epidermal Necrolysis
Adverse event was reported on Mar 31, 2009 by a Male patient taking Klacid (View Usage) (Dosage: ) was diagnosed with myocardial ischaemia, hypertension, hyperlipidaemia and. Location: SINGAPORE , 67 years of age, Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LOSEC (View Losec Review and Losec Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TICLID (View Ticlid Review and Ticlid Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ). Patient was hospitalized.

6122725-2 | Asthenia, Headache, Somnolence
on Mar 16, 2009 Male patient from PORTUGAL , weighting 39.68 lb, was treated with Klacid (View Usage). Patient had the following side effects: asthenia, headache (What is headache?), somnolence. Klacid dosage: . During the same period patient was treated with BRUFEN (View Brufen Review and Brufen Label ).

6121513-0 | Coronary Artery Stenosis, Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Inversion, Torsade De Pointes
on Mar 13, 2009 Female patient from SWITZERLAND , 75 years of age, weighting 222.7 lb, was diagnosed with lung infiltration and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: coronary artery stenosis, electrocardiogram qt prolonged, electrocardiogram t wave inversion, torsade de pointes. Klacid dosage: . During the same period patient was treated with CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ). Patient was hospitalized.

6113644-6 | Cholestasis, Hepatic Steatosis, Hepatomegaly, Jaundice
Patient was taking Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatic steatosis, hepatomegaly, jaundice (What is jaundice?) on Mar 05, 2009 from SWEDEN Additional patient health information: Male patient , 65 years of age, was diagnosed with duodenitis, duodenal ulcer and. Klacid dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), IMACILLIN (View Imacillin Review and Imacillin Label ). Patient was hospitalized.

6106309-8 | Coronary Artery Stenosis, Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Inversion, Torsade De Pointes
Adverse event was reported on Feb 26, 2009 by a Female patient taking Klacid (View Usage) (Dosage: ) was diagnosed with lung infiltration and. Location: SWITZERLAND , 75 years of age, Patient had the following side effects: coronary artery stenosis, electrocardiogram qt prolonged, electrocardiogram t wave inversion, torsade de pointes. During the same period patient was treated with CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ). Patient was hospitalized.

6106306-2 | Cholestasis, Hepatic Steatosis, Hepatomegaly, Jaundice
on Feb 27, 2009 Male patient from SWEDEN , 65 years of age, was diagnosed with duodenitis, duodenal ulcer and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: cholestasis, hepatic steatosis, hepatomegaly, jaundice (What is jaundice?). Klacid dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), IMACILLIN (View Imacillin Review and Imacillin Label ). Patient was hospitalized.

6043271-0 | Diarrhoea, Hyperkalaemia, Sinoatrial Block
on Jan 12, 2009 Female patient from GERMANY , 66 years of age, weighting 198.4 lb, was diagnosed with gastritis bacterial, hypertension, ascites, blood uric acid increased and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hyperkalaemia, sinoatrial block. Klacid dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), TOREM (View Torem Review and Torem Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

6030037-0 | Asthenia, Cardiac Arrest, Confusional State, Haemodialysis, Hyperkalaemia, Loss Of Consciousness, Renal Tubular Necrosis
Patient was taking Klacid (View Usage). Patient had the following side effects: asthenia, cardiac arrest (What is cardiac arrest?), confusional state, haemodialysis, hyperkalaemia, loss of consciousness, renal tubular necrosis on Dec 30, 2008 from UNITED KINGDOM Additional patient health information: Male patient , weighting 157.6 lb, was diagnosed with mycobacterium avium complex infection, pneumocystis jiroveci pneumonia, hiv infection (What is hiv infection?), insomnia and. Klacid dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), ATRIPLA (View Atripla Review and Atripla Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), TRUVADA (View Truvada Review and Truvada Label ), TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ). Patient was hospitalized.

5961907-7 | Cerebral Haemorrhage, Circulatory Collapse, International Normalised Ratio Increased, Malaise
Adverse event was reported on Nov 16, 2008 by a Female patient taking Klacid (View Usage) (Dosage: ) was diagnosed with respiratory tract infection, heart rate irregular, cerebrovascular accident prophylaxis and. Location: IRELAND , 69 years of age, After Klacid was administered, patient had the following side effects: cerebral haemorrhage, circulatory collapse, international normalised ratio increased, malaise. During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AUGMENTIN '125' (For One Week) (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5954106-6 | Cerebral Haemorrhage, Circulatory Collapse, International Normalised Ratio Increased, Malaise
on Nov 10, 2008 Female patient from IRELAND , 69 years of age, was diagnosed with respiratory tract infection, heart rate irregular, cerebrovascular accident prophylaxis and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, circulatory collapse, international normalised ratio increased, malaise. Klacid dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AUGMENTIN '125' (For One Week) (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5949994-3 | Confusional State, Dysarthria, Dysphasia
on Nov 06, 2008 Female patient from AUSTRALIA , weighting 209.4 lb, was diagnosed with urinary tract disorder and was treated with Klacid (View Usage). Patient had the following side effects: confusional state, dysarthria, dysphasia. Klacid dosage: . Patient was hospitalized.

5945627-0 | Cerebral Haemorrhage, Circulatory Collapse, International Normalised Ratio Increased, Malaise
Patient was taking Klacid (View Usage). After Klacid was administered, patient had the following side effects: cerebral haemorrhage, circulatory collapse, international normalised ratio increased, malaise on Oct 31, 2008 from IRELAND Additional patient health information: Female patient , 69 years of age, was diagnosed with respiratory tract infection, heart rate irregular, cerebrovascular accident prophylaxis and. Klacid dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AUGMENTIN '125' (For One Week) (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5919475-1 | Dermatitis Allergic
Adverse event was reported on Oct 14, 2008 by a Female patient taking Klacid (View Usage) (Dosage: Not Reported) . Location: CZECH REPUBLIC , 58 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis allergic.

5909513-4 | Dermatitis Allergic
on Sep 30, 2008 Female patient from CZECH REPUBLIC , 58 years of age, was treated with Klacid (View Usage). Patient had the following side effects: dermatitis allergic. Klacid dosage: Not Reported.

5889900-3 | Dermatitis Exfoliative, Dyspnoea, Tachycardia
on Sep 17, 2008 Male patient from SWITZERLAND , 31 years of age, was diagnosed with lobar pneumonia and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: dermatitis exfoliative, dyspnoea, tachycardia. Klacid dosage: . During the same period patient was treated with PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ).

5876910-5 | Dermatitis Exfoliative, Dyspnoea, Tachycardia
Patient was taking Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, dyspnoea, tachycardia on Sep 04, 2008 from SWITZERLAND Additional patient health information: Male patient , 31 years of age, was diagnosed with lobar pneumonia and. Klacid dosage: . During the same period patient was treated with PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ).

5773974-4 | Hypomania
Adverse event was reported on Jun 09, 2008 by a Female patient taking Klacid (View Usage) (Dosage: ) was diagnosed with lower respiratory tract infection and. Location: IRELAND , 66 years of age, Patient had the following side effects: hypomania. During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5745050-8 | Ventricular Tachycardia
on May 14, 2008 Male patient from ITALY , weighting 196.2 lb, was diagnosed with nasopharyngitis and was treated with Klacid (View Usage). After Klacid was administered, patient had the following side effects: ventricular tachycardia. Klacid dosage: . During the same period patient was treated with BENTALAN (View Bentalan Review and Bentalan Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).

5724186-1 | Bipolar Disorder, Extrapyramidal Disorder
on Apr 25, 2008 Female patient from IRELAND , 54 years of age, weighting 209.4 lb, was diagnosed with lower respiratory tract infection, bipolar disorder (What is bipolar disorder?) and was treated with Klacid (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar disorder (What is bipolar disorder?), extrapyramidal disorder. Klacid dosage: . During the same period patient was treated with TEGRETOL (Not Reported) (View Tegretol Review and Tegretol Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

5699550-X | Intra-abdominal Haemorrhage, Prothrombin Level Decreased
Patient was taking Klacid (View Usage). Patient had the following side effects: intra-abdominal haemorrhage, prothrombin level decreased on Apr 01, 2008 from SWEDEN Additional patient health information: Female patient , 67 years of age, was diagnosed with pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?) and. Klacid dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NITROLINGUAL SUBLINGUAL (View Nitrolingual Sublingual Review and Nitrolingual Sublingual Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.